Russell Investments Group, Ltd.

Position in ACRS — Aclaris Therapeutics, Inc.

CIK 1692234 Seattle, WA

Position in ACRS

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$1,155,617

+$1,126,165 QoQ

Shares Held

308,165

+3049.4% QoQ

Ownership

0.221%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 90.4083851183619.ToString("F0")% Shared 0.ToString("F0")% None 9.591614881638083.ToString("F0")%

Healthcare · as of Mar 31, 2026

Russell Investments Group, Ltd. holds $1,223,802,944 across 266 Biotechnology names. ACRS ranks #90 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	228,086	$176,228,356
2	VRTX	Vertex Pharmaceuticals Inc / Ma	367,691	$164,188,731
3	RPRX	Royalty Pharma plc	1,397,958	$67,060,041
4	INCY	Incyte Corp	638,242	$60,071,331
5	ALNY	Alnylam Pharmaceuticals, Inc.	147,533	$48,814,236
6	MRNA	Moderna, Inc.	710,640	$36,100,509
7	BMRN	Biomarin Pharmaceutical Inc	606,224	$34,245,589
8	INSM	INSMED Inc	169,162	$27,661,365

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,155,617	308,165	+3049.4%	Shares	Defined	2026-05-08
2025-12-31	$29,452	9,785	+1.8%	Shares	Defined	2026-02-17
2025-09-30	$18,262	9,612	+1195.4%	Shares	Defined	2025-11-13
2025-06-30	$1,053	742	-64.6%	Shares	Defined	2025-08-13
2025-03-31	$3,203	2,094	-24.3%	Shares	Defined	2025-05-13
2024-12-31	$6,857	2,765	0.0%	Shares	Defined	2025-02-13
2024-09-30	$3,179	2,765	-22.1%	Shares	Defined	2024-11-13
2024-06-30	$3,905	3,550	-94.3%	Shares	Defined	2024-08-08
2024-03-31	$77,836	62,772	+5265.1%	Shares	Defined	2024-05-08
2023-12-31	$1,228	1,170	+3445.5%	Shares	Defined	2024-02-05
2023-09-30	$226	33	—	Shares	Defined	2023-11-13
No filing history on record for this holder in this stock.